Global healthcare giant Abbott Laboratories (ABT) is gearing up to release its third-quarter financial results on Wednesday, October 15, ahead of the opening bell.
With Wall Street closely watching for signs of margin stability and segment-level momentum, the Q3 scorecard is poised to offer insight into how the company is managing post-pandemic normalization while advancing its innovation-led growth strategy.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com